Nano Dimension's $890M Infinite Epigenetics Deal Stalls as Exclusivity Expires
NNDM sits 34% above its 52-week low of $1.19 on light trading volume (0.4× avg).
Summary
Nano Dimension's proposed $890 million acquisition of Infinite Epigenetics has stalled after the exclusivity period expired without a definitive agreement. The company also appointed Nadav Kidron to its board.
Key Events · M&A and Partnerships · NNDM
-
Infinite Epigenetics Deal Stalls
The 30-day exclusivity period under the non-binding term sheet expired on July 15, 2026, and as of August 16, 2026, no definitive agreement has been reached.
-
Strategic Pivot in Limbo
The $890 million acquisition was central to Nano Dimension's pivot into epigenetics and its defense against activist Murchinson; its stall leaves the company's direction uncertain.
-
New Director Appointed
Nadav Kidron, CEO of Oramed Pharmaceuticals, was appointed to the board as a Class II director, effective immediately, and will serve on the Audit and Compensation Committees.
-
Next Milestone Unclear
The filing does not state whether negotiations will continue or if the company will pursue alternative strategies.
Analysis · NNDM · Manufacturing
The non-binding term sheet to acquire Infinite Epigenetics for $890 million has lapsed without a definitive agreement. The 30-day exclusivity period ended July 15, 2026, and as of August 16, 2026, no deal has been reached. This is a material setback for the company's strategic pivot, which was announced in June 2026 and was a central element of its defense against activist investor Murchinson. The appointment of Nadav Kidron, an experienced life sciences executive, to the board may signal a continued focus on the healthcare sector, but the stalled acquisition leaves the company's strategic direction uncertain.
At the time of this filing, NNDM was trading at $1.59 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $334.8M. The 52-week trading range was $1.19 to $2.32. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.